Stock UniverseDerived research view · source repositories remain read-only

ImmunityBio, Inc. (IBRX)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
High
Selection Score
40.87
Global Rank
320
Market Cap
10.05B
Latest Close
6.92
RS Composite
71.18% · G#78

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
-17.42%
3M
-20.18%
6M
214.55%
1Y
136.18%
3Y
151.64%
5Y
-60.57%
10Y
-9.19%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 13.56M · 30-day average: 13.92M · Max drawdown over stored range: -97.03%

Research Snapshot

Relative Strength vs SPX

RS Composite71.18%
20D RS-11.46%
60D RS-25.30%
120D RS208.99%
Global RS Rank78 · 97.68% percentile
Qualified+ RS Rank38 · 96.98% percentile
Group ScopeQualified+
Primary RS Rank12 · 97.38% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank25 / 701
Primary Percentile96.58
Score Notesmarket-cap support, industry-tailwind

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

PeriodFiledRevenueGross ProfitOperating IncomeNet IncomeEPS DilutedOperating Cash FlowCapital ExpenditureFree Cash FlowShares DilutedGross MarginOperating MarginNet MarginOCF MarginFCF MarginCash + ST Inv.Total Debt
TTM through 2026-03-312026-05-07140.98M140.04M-261.39M-854.53M-0.89-545.95M7.82M-553.77M963M99.34%-1.85%-6.06%-3.87%-3.93%380.88M25.00M

SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

TTM Valuation

PeriodEPS DilutedP/ERevenue / ShareP/SFCF / ShareP/FCF MultipleOCF / ShareP/CF Multiple
TTM through 2026-03-31$-0.89-7.8x$0.1547.3x$-0.58-12.0x$-0.57-12.2x

Shares Diluted: 963M. SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue0.6050.9340.240.62214.745113.288
Revenue Growth (YoY)-72.525%54.38%-74.304%159.167%2270.579%668.315%
Gross Profit0.6050.9340.240.62214.745112.535
Operating Income-200.673-317.424-350.668-361.363-344.183-256.027
Free Cash Flow-173.393-307.982-415.671-397.341-398.124-308.782
Free Cash Flow Per Share-0.46-0.791-1.039-0.781-0.568-0.336
EPS (Diluted) GAAP-0.588358-0.890954-1.041677-1.15-0.618872-0.382011
EPS Growth
EPS Non-GAAP
Gross Margin100%100%100%100%100%99.335%
Operating Margin-33169.091%-33985.439%-146111.667%-58096.945%-2334.235%-225.997%
Profit Margin-36669.587%-37129.55%-173569.583%-93761.415%-2804.774%-310.181%
Free Cash Flow Margin-28660.0%-32974.518%-173196.25%-63881.19%-2700.061%-272.564%
Shares Outstanding (Diluted)377.0675389.2342399.9508.636700.443919.863
Shares Change (YoY)2.933%3.227%2.74%27.191%37.71%31.326%

SEC Quarterly Fundamentals

Revenue + Operating Margin
Loading SEC quarterly chart...
Revenue Operating Margin
Quarter Filed Revenue Gross Margin Operating Income Op Margin Net Income Net Margin EPS Diluted Shares Diluted Cash + ST Inv. Total Debt Confidence
2026 Q12026-05-0744.21M99.46%-69.79M-1.58%-632.78M-14.31%-0.621.03B380.88M25.00Mprocessed
2025 Q42026-02-2338.28M99.00%-64.68M-1.69%-61.94M-1.62%-0.06990.45M242.82M505.00Mprocessed
2025 Q32025-11-0532.06M99.45%-55.63M-1.74%-67.25M-2.10%-0.07946.60M257.81M505.00Mprocessed
2025 Q22025-08-0526.43M99.49%-71.28M-2.70%-92.56M-3.50%-0.10888.22M153.66M505.00Mprocessed
2025 Q12025-05-1216.52M99.65%-64.43M-3.90%-129.65M-7.85%-0.15853.16M61.59M505.00Mprocessed
2024 Q42025-03-037.55Mn/a-69.40M-9.19%-59.16M-7.83%-0.08734.96M149.81M104.59Mprocessed
2024 Q32024-11-126.11Mn/a-80.25M-13.14%-85.73M-14.04%-0.14697.96M130.37M111.14Mprocessed
2024 Q22024-08-121.05Mn/a-99.33M-94.87%-134.56M-128.52%-0.20686.94M217.98M263.34Mprocessed
2024 Q12024-05-0940.00Kn/a-95.20M-2379.90%-134.11M-3352.73%-0.20672.83M170.50M163.42Mprocessed
2023 Q42024-03-19139.00Kn/a-85.39M-614.31%-233.39M-1679.08%-0.35669.56M266.46M155.41Mprocessed
2023 Q32023-11-0982.00Kn/a-80.14M-977.27%-95.58M-1165.63%-0.19498.38M189.80M480.02Mprocessed
2023 Q22023-08-0841.00Kn/a-85.14M-2076.71%-137.88M-3362.90%-0.32437.46M45.95M36.60Mprocessed
2023 Q12023-05-11360.00Kn/a-111.58M-309.94%-116.34M-323.18%-0.27428.38M91.27M263.23Mprocessed
2022 Q42023-03-0173.00Kn/a-84.90M-1163.01%-108.22M-1482.40%-0.27403.64M107.18M233.23Mprocessed
2022 Q32022-11-09118.00Kn/a-90.80M-769.53%-110.94M-940.15%-0.28400.06M111.06M276.64Mprocessed
2022 Q22022-08-0835.00Kn/a-79.62M-2274.91%-94.59M-2702.51%-0.24397.99M82.94M576.64Mprocessed
2022 Q12022-05-1014.00Kn/a-95.97M-6855.14%-102.83M-7344.71%-0.26397.88M192.33M576.64Mprocessed
2021 Q42022-03-01390.00Kn/a-79.27M-203.27%-91.26M-234.00%-0.23397.12M317.12M576.64Mprocessed
2021 Q32021-11-1266.00Kn/a-78.84M-1194.48%-87.63M-1327.71%-0.22391.85M80.37Mn/aprocessed
2021 Q22021-08-12339.00Kn/a-85.91M-253.41%-88.29M-260.44%n/an/a103.93Mn/aprocessed

SEC processed quarterly CSV. Compact derived quarterly view from SEC processed CSV. Source files remain read-only in the SEC repository. EPS is as filed and may not be split-adjusted across older periods. StockAnalysis Financial Statement Metrics remain unchanged above.